These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. B.1.526 SARS-CoV-2 Variants Identified in New York City are Neutralized by Vaccine-Elicited and Therapeutic Monoclonal Antibodies. Zhou H; Dcosta BM; Samanovic MI; Mulligan MJ; Landau NR; Tada T mBio; 2021 Aug; 12(4):e0138621. PubMed ID: 34311587 [TBL] [Abstract][Full Text] [Related]
11. Resistance of SARS-CoV-2 variants to neutralization by antibodies induced in convalescent patients with COVID-19. Kaku Y; Kuwata T; Zahid HM; Hashiguchi T; Noda T; Kuramoto N; Biswas S; Matsumoto K; Shimizu M; Kawanami Y; Shimura K; Onishi C; Muramoto Y; Suzuki T; Sasaki J; Nagasaki Y; Minami R; Motozono C; Toyoda M; Takahashi H; Kishi H; Fujii K; Tatsuke T; Ikeda T; Maeda Y; Ueno T; Koyanagi Y; Iwagoe H; Matsushita S Cell Rep; 2021 Jul; 36(2):109385. PubMed ID: 34237284 [TBL] [Abstract][Full Text] [Related]
12. In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Chen RE; Winkler ES; Case JB; Aziati ID; Bricker TL; Joshi A; Darling TL; Ying B; Errico JM; Shrihari S; VanBlargan LA; Xie X; Gilchuk P; Zost SJ; Droit L; Liu Z; Stumpf S; Wang D; Handley SA; Stine WB; Shi PY; Davis-Gardner ME; Suthar MS; Knight MG; Andino R; Chiu CY; Ellebedy AH; Fremont DH; Whelan SPJ; Crowe JE; Purcell L; Corti D; Boon ACM; Diamond MS Nature; 2021 Aug; 596(7870):103-108. PubMed ID: 34153975 [TBL] [Abstract][Full Text] [Related]
14. Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency. Mariotti S; Capocefalo A; Chiantore MV; Iacobino A; Teloni R; De Angelis ML; Gallinaro A; Pirillo MF; Borghi M; Canitano A; Michelini Z; Baggieri M; Marchi A; Bucci P; McKay PF; Acchioni C; Sandini S; Sgarbanti M; Tosini F; Di Virgilio A; Venturi G; Marino F; Esposito V; Di Bonito P; Magurano F; Cara A; Negri D; Nisini R Front Immunol; 2021; 12():750386. PubMed ID: 34764961 [TBL] [Abstract][Full Text] [Related]
15. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Liu C; Ginn HM; Dejnirattisai W; Supasa P; Wang B; Tuekprakhon A; Nutalai R; Zhou D; Mentzer AJ; Zhao Y; Duyvesteyn HME; López-Camacho C; Slon-Campos J; Walter TS; Skelly D; Johnson SA; Ritter TG; Mason C; Costa Clemens SA; Gomes Naveca F; Nascimento V; Nascimento F; Fernandes da Costa C; Resende PC; Pauvolid-Correa A; Siqueira MM; Dold C; Temperton N; Dong T; Pollard AJ; Knight JC; Crook D; Lambe T; Clutterbuck E; Bibi S; Flaxman A; Bittaye M; Belij-Rammerstorfer S; Gilbert SC; Malik T; Carroll MW; Klenerman P; Barnes E; Dunachie SJ; Baillie V; Serafin N; Ditse Z; Da Silva K; Paterson NG; Williams MA; Hall DR; Madhi S; Nunes MC; Goulder P; Fry EE; Mongkolsapaya J; Ren J; Stuart DI; Screaton GR Cell; 2021 Aug; 184(16):4220-4236.e13. PubMed ID: 34242578 [TBL] [Abstract][Full Text] [Related]
16. Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Carreño JM; Alshammary H; Tcheou J; Singh G; Raskin AJ; Kawabata H; Sominsky LA; Clark JJ; Adelsberg DC; Bielak DA; Gonzalez-Reiche AS; Dambrauskas N; Vigdorovich V; ; Srivastava K; Sather DN; Sordillo EM; Bajic G; van Bakel H; Simon V; Krammer F Nature; 2022 Feb; 602(7898):682-688. PubMed ID: 35016197 [TBL] [Abstract][Full Text] [Related]
17. The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom. Wu J; Zhang L; Zhang Y; Wang H; Ding R; Nie J; Li Q; Liu S; Yu Y; Yang X; Duan K; Qu X; Wang Y; Huang W Front Immunol; 2021; 12():687869. PubMed ID: 34220844 [TBL] [Abstract][Full Text] [Related]
18. Limited Variation between SARS-CoV-2-Infected Individuals in Domain Specificity and Relative Potency of the Antibody Response against the Spike Glycoprotein. Van Ert HA; Bohan DW; Rogers K; Fili M; Rojas Chávez RA; Qing E; Han C; Dempewolf S; Hu G; Schwery N; Sevcik K; Ruggio N; Boyt D; Pentella MA; Gallagher T; Jackson JB; Merrill AE; Knudson CM; Brown GD; Maury W; Haim H Microbiol Spectr; 2022 Feb; 10(1):e0267621. PubMed ID: 35080430 [TBL] [Abstract][Full Text] [Related]
19. Reduced sensitivity of the SARS-CoV-2 Lambda variant to monoclonal antibodies and neutralizing antibodies induced by infection and vaccination. Wang M; Zhang L; Li Q; Wang B; Liang Z; Sun Y; Nie J; Wu J; Su X; Qu X; Li Y; Wang Y; Huang W Emerg Microbes Infect; 2022 Dec; 11(1):18-29. PubMed ID: 34818119 [TBL] [Abstract][Full Text] [Related]
20. Elicitation of Broadly Neutralizing Antibodies against B.1.1.7, B.1.351, and B.1.617.1 SARS-CoV-2 Variants by Three Prototype Strain-Derived Recombinant Protein Vaccines. Yang Y; Zang J; Xu S; Zhang X; Yuan S; Wang H; Lavillette D; Zhang C; Huang Z Viruses; 2021 Jul; 13(8):. PubMed ID: 34452287 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]